Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Capital Expenditures (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Capital Expenditures readings, the most recent being $2000.0 for Q1 2026.

  • Quarterly Capital Expenditures fell 99.48% to $2000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $327000.0 through Mar 2026, down 75.9% year-over-year, with the annual reading at $712000.0 for FY2025, 40.07% down from the prior year.
  • Capital Expenditures hit $2000.0 in Q1 2026 for Oric Pharmaceuticals, down from $227000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $723000.0 in Q1 2022 and bottomed at $2000.0 in Q1 2026.
  • Average Capital Expenditures over 5 years is $284058.8, with a median of $287000.0 recorded in 2022.
  • The largest annual shift saw Capital Expenditures surged 442.86% in 2024 before it plummeted 99.48% in 2026.
  • Oric Pharmaceuticals' Capital Expenditures stood at $287000.0 in 2022, then crashed by 80.14% to $57000.0 in 2023, then soared by 284.21% to $219000.0 in 2024, then increased by 3.65% to $227000.0 in 2025, then plummeted by 99.12% to $2000.0 in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Capital Expenditures are $2000.0 (Q1 2026), $227000.0 (Q4 2025), and $35000.0 (Q3 2025).